Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000587553 | SCV000335107 | uncertain significance | not provided | 2015-09-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000587553 | SCV000534302 | likely benign | not provided | 2019-10-24 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000587553 | SCV000699966 | benign | not provided | 2017-07-18 | criteria provided, single submitter | clinical testing | Variant summary: The LMNA c.1051A>C (p.Arg351Arg) variant involves the alteration of a non-conserved nucleotide causing a synonymous change and 4/5 splice prediction tools predict no significant impact on normal splicing. ESE finder predicts that this variant may affect ESE sites. However, these predictions have yet to be confirmed by functional studies. This variant was found in 14/120768 control chromosomes, predominantly observed in the Latino subpopulation at a frequency of 0.001212 (14/11554). This frequency is about 12 times the estimated maximal expected allele frequency of a pathogenic LMNA variant (0.0001042), suggesting this is likely a benign polymorphism found primarily in the populations of Latino origin. In addition, multiple clinical diagnostic laboratories have cited the variant with conflicting classifications "likely benign" or "uncertain significance." The variant of interest has not, to our knowledge, been reported in affected individuals via publications. Due to the nature of the variant being synonymous and the high frequency in controls, the variant of interest has been classified as Benign. |
Labcorp Genetics |
RCV001088944 | SCV001012988 | likely benign | Charcot-Marie-Tooth disease type 2 | 2023-12-06 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001183035 | SCV001348685 | likely benign | Cardiomyopathy | 2018-11-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002392800 | SCV002704037 | likely benign | Cardiovascular phenotype | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV003995764 | SCV004818233 | likely benign | Primary dilated cardiomyopathy | 2023-12-18 | criteria provided, single submitter | clinical testing |